Korro Bio (KRRO) Capital Expenditures Growth (3y) (2021 - 2026)
Korro Bio (KRRO) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -75.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.97% |
| Dec 31, 2025 | -74.62% |
| Sep 30, 2025 | 134.76% |
| Jun 30, 2025 | 227.11% |
| Mar 31, 2025 | 114.84% |
| Dec 31, 2024 | 187.66% |
| Sep 30, 2024 | 32.58% |
| Jun 30, 2024 | 98.12% |
| Mar 31, 2024 | 46.30% |
| Dec 31, 2023 | -27.91% |
| Sep 30, 2023 | -37.36% |
| Jun 30, 2023 | 69.44% |
| Mar 31, 2023 | 64.00% |
| Dec 31, 2022 | 72.94% |
| Sep 30, 2022 | 66.27% |
| Jun 30, 2022 | -48.33% |
| Mar 31, 2022 | -70.32% |
| Dec 31, 2021 | -36.57% |